KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biolife Solutions (BLFS) Accumulated Depreciation & Amortization (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 56.34% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 56.34% decrease, with the full-year FY2025 number at $2.3 million, down 56.34% from a year prior.
  • Accumulated Depreciation & Amortization was $2.3 million for Q4 2025 at Biolife Solutions, up from $2.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $7.1 million in Q1 2022 to a low of $682000.0 in Q1 2025.
  • A 5-year average of $3.9 million and a median of $4.0 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 61.55% in 2022, then crashed 75.88% in 2023.
  • Biolife Solutions' Accumulated Depreciation & Amortization stood at $4.7 million in 2021, then surged by 45.29% to $6.8 million in 2022, then rose by 5.0% to $7.1 million in 2023, then decreased by 27.47% to $5.2 million in 2024, then tumbled by 56.34% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Accumulated Depreciation & Amortization are $2.3 million (Q4 2025), $2.0 million (Q3 2025), and $1.4 million (Q2 2025).